Sari Reisner

Trained as a social and psychiatrist epidemiologist, Dr. Reisner’s research focuses on understanding and mitigating health inequities for LGBTQIA+ populations, particularly in mental health and substance use, HIV infection, and healthcare access and quality outcomes. Dr. Reisner brings deep expertise in transgender and gender diverse population health, community-engaged research methods and peer-delivered interventions, cohort study and clinical trial design, and social determinants of health. His work utilizes a “participatory population perspective” (Reisner et al., Lancet, 2016) to work “with” not “on” communities to promote health equity.
Dr. Reisner is/has been PI of multiple research investigations funded by the National Institutes of Health (NIH), Patient-Centered Outcomes Research Institute (PCORI), and others in domestic and global contexts. He has co-authored more than 300 peer-reviewed publications and led a chapter in the WPATH Standards of Care Version 8, the preeminent guidelines for healthcare of transgender people globally. Dr. Reisner was appointed by the National Academies of Sciences, Engineering, and Medicine (NASEM) as a Committee Member to conduct a national consensus study on the health of sexual and gender minorities which was published in 2020. In 2022, he became an elected Board Member for the World Professional Association for Transgender Health (WPATH). He is a founding Associate Research Editor of the PubMed-indexed journal Transgender Health.